<table border="1" id="id_ecd269b0-a1b4-4b88-a973-559f5d085b36" width="872.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_6dd2353f-58bc-4201-99a8-2e0c6fdcdbab">Table 2 Incidence of Primary Endpoint Events</caption>
<col width="14.0%"></col>
<col width="12.4%"></col>
<col width="12.4%"></col>
<col width="11.4%"></col>
<col width="12.7%"></col>
<col width="12.7%"></col>
<col width="11.7%"></col>
<col width="12.7%"></col>
<tbody>
<tr id="id_6bcb0e86-120c-4833-a57e-6fab03e838b4" stylecode="Toprule">
<td align="left" valign="top"> </td>
<td align="center" colspan="2" stylecode="Toprule" valign="top">Losartan<br/>Potassium</td>
<td align="center" colspan="2" stylecode="Toprule" valign="top">Atenolol</td>
<td align="center" stylecode="Toprule" valign="top">Risk<br/>Reduction<footnote id="id-2a34b39e-8e6a-4035-909e-e19e8f7c98c9">Adjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypertrophy</footnote>
</td>
<td align="center" stylecode="Toprule" valign="top">95% CI</td>
<td align="center" valign="top">p-Value</td>
</tr>
<tr id="id_afb5168f-49cd-4d7d-ac82-af8038575b40">
<td align="left" valign="top"> </td>
<td align="center" valign="top">N (%)</td>
<td align="center" valign="top">Rate<footnote id="id-138623c5-65af-4066-97e3-21702cee6525">Rate per 1,000 patient-years of follow-up</footnote>
</td>
<td align="center" valign="top">N (%)</td>
<td align="center" valign="top">Rate<sup>†</sup>
</td>
<td align="center" valign="top">  </td>
<td align="center" valign="top">  </td>
<td align="center" valign="top">  </td>
</tr>
<tr id="id_18a303db-e405-43dd-999f-f962db3abbe7">
<td align="left" valign="top">Primary Composite Endpoint</td>
<td align="center" valign="top">508 (11)</td>
<td align="center" valign="top">23.8</td>
<td align="center" valign="top">588 (13)</td>
<td align="center" valign="top">27.9</td>
<td align="center" valign="top">13%</td>
<td align="center" valign="top">2% to 23%</td>
<td align="center" valign="top">0.021</td>
</tr>
<tr id="id_7aba868a-52e6-4acf-a117-8959d7a806b8">
<td align="left" colspan="8" valign="top">Components of Primary Composite Endpoint (as a first event)</td>
</tr>
<tr id="id_e5366214-d45a-4d20-924e-b9b17990c19a">
<td align="left" valign="top">     Stroke (nonfatal<footnote id="id-6d1f8166-6f6e-4225-922d-3fe4bb16677c">First report of an event, in some cases the patient died subsequently to the event reported</footnote> ) </td>
<td align="center" valign="top">209 (5)</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top">286 (6)</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr id="id_779828a3-4529-4541-9247-77b562899c8d">
<td align="left" valign="top">     Myocardial infarction (nonfatal<sup>‡</sup> )</td>
<td align="center" valign="top">174 (4)</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top">168 (4)</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr id="id_d5ba1fd8-a5d0-4eae-9a7b-2abd7b384351">
<td align="left" valign="top">     Cardiovascular mortality</td>
<td align="center" valign="top">125 (3)</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top">134 (3)</td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
<td align="center" valign="top"> </td>
</tr>
<tr id="id_f074ad77-10c0-43c9-943b-12b8d98eb00f">
<td align="left" colspan="8" valign="top">Secondary Endpoints (any time in study)</td>
</tr>
<tr id="id_537c7115-0dc9-41e5-9a36-c52e909d5f1c">
<td align="left" valign="top">Stroke (fatal/nonfatal)</td>
<td align="center" valign="top">232 (5)</td>
<td align="center" valign="top">10.8</td>
<td align="center" valign="top">309 (7)</td>
<td align="center" valign="top">14.5</td>
<td align="center" valign="top">25%</td>
<td align="center" valign="top">11% to 37%</td>
<td align="center" valign="top">0.001</td>
</tr>
<tr id="id_451ae089-1e5f-4f5a-bfb0-63ecfbca67c8">
<td align="left" valign="top">Myocardial infarction (fatal/nonfatal)</td>
<td align="center" valign="top">198 (4)</td>
<td align="center" valign="top">9.2</td>
<td align="center" valign="top">188 (4)</td>
<td align="center" valign="top">8.7</td>
<td align="center" valign="top">-7%</td>
<td align="center" valign="top">-13% to 12%</td>
<td align="center" valign="top">0.491</td>
</tr>
<tr id="id_7ba5ee7c-2e0e-4870-917c-d68aebed4e2e">
<td align="left" valign="top">Cardiovascular mortality</td>
<td align="center" valign="top">204 (4)</td>
<td align="center" valign="top">9.2</td>
<td align="center" valign="top">234 (5)</td>
<td align="center" valign="top">10.6</td>
<td align="center" valign="top">11%</td>
<td align="center" valign="top">-7% to 27%</td>
<td align="center" valign="top">0.206</td>
</tr>
<tr id="id_3bc0b72d-993f-4c90-969e-2d4bdf12ee0a">
<td align="left" valign="top">     Due to CHD</td>
<td align="center" valign="top">125 (3)</td>
<td align="center" valign="top">5.6</td>
<td align="center" valign="top">124 (3)</td>
<td align="center" valign="top">5.6</td>
<td align="center" valign="top">-3%</td>
<td align="center" valign="top">-32% to 20%</td>
<td align="center" valign="top">0.839</td>
</tr>
<tr id="id_b8ddcde7-f5be-4334-b1e0-6bfc49a22b55">
<td align="left" valign="top">     Due to Stroke</td>
<td align="center" valign="top">40 (1)</td>
<td align="center" valign="top">1.8</td>
<td align="center" valign="top">62 (1)</td>
<td align="center" valign="top">2.8</td>
<td align="center" valign="top">35%</td>
<td align="center" valign="top">4% to 67%</td>
<td align="center" valign="top">0.032</td>
</tr>
<tr id="id_2114a20a-6dfe-4a54-90a8-af8e6950f58b" stylecode="Botrule">
<td align="left" valign="top">     Other<footnote id="id-39eb43ad-ccaf-4f6d-9743-0c413fedaeb2">Death due to heart failure, non-coronary vascular disease, pulmonary embolism or a cardiovascular cause other than stroke or coronary heart disease</footnote>
</td>
<td align="center" valign="top">39 (1)</td>
<td align="center" valign="top">1.8</td>
<td align="center" valign="top">48 (1)</td>
<td align="center" valign="top">2.2</td>
<td align="center" valign="top">16%</td>
<td align="center" valign="top">-28% to 45%</td>
<td align="center" valign="top">0.411</td>
</tr>
</tbody>
</table>